The White House budget proposal for 2020 recommends increases to the domestic HIV programs at the U.S. Centers for Disease Control and Prevention, the Health Resources and Services Administration and Indian Health Services that will be essential to keeping the administration’s promise of ending our nation’s HIV epidemic in the next decade.
The NHAS has served as a critical roadmap for strengthening our nation’s response to the HIV epidemic, and a strong commitment to ensuring the NHAS’ continued relevance as an evidence-based and outcomes-oriented guide is important to not lose ground and to achieve the administration’s proposal to end the HIV epidemic.
More than 400 physicians and scientists urged Congressional appropriators to increase U.S. support for the Global Fund to Fight AIDS, Tuberculosis and Malaria during the international partnership’s upcoming funding cycle in a letter released today.
Despite the emphatic objections from medical providers’ associations nationwide, including the HIV Medicine Association, the administration has chosen to compromise the crucial trust between physicians and patients, further erode access to basic healthcare
A District Court injunction preventing the military discharge of two Air Force members living with HIV was responsive to medical evidence and reflected important recognition of advances in treatment for HIV
The 2019 spending bill passed by the House and Senate Thursday that the President has announced he will sign, reflects a meaningful commitment to moving our country forward and to continued U.S. leadership of the fight against the world’s most devastating infectious disease killers.
The President’s goal to end the HIV epidemic in the United States within the next 10 years, announced in his State of the Union Address is laudable and critically important to the strength and well-being of our nation.
HIVMA recognizes and supports efforts to negotiate lower drug prices and reduce out-of-pocket costs for Medicare beneficiaries. However, we are concerned that the proposed rule would undermine patient care by eroding Part D policies that were put in place by CMS to negate insurer discriminatory practices. Lower drug prices must not come at the expense of poorer health outcomes for Medicare beneficiaries as one of the goals of reducing is to expand and improve access to high quality health care and treatment.
The Supreme Court’s decision today allowing the Trump administration to put into effect a discriminatory ban against military service by transgender people
The Dec. 27 federal injunction stopping cuts in 340B reimbursements for Medicare Part B drugs to some hospitals helps preserve the role academic health centers play in providing ID treatment and prevention services to patients who lack care options.
HIVMA, IDSA, PIDS and RWMPC submitted public comments to the Department of Homeland Security, asking the administration to seriously consider implications of the “public charge” rule on health of immigrants and their families and access to treatment preventive services for communicable diseases, and to withdraw the proposed rule.
On World AIDS Day, The Hill Congress blog published an opinion piece I wrote to draw attention to policies that compromise U.S. leadership of global AIDS responses, and the success of responses at home.